Previous Page  5 / 26 Next Page
Information
Show Menu
Previous Page 5 / 26 Next Page
Page Background

Page 56

Notes:

Volume 4, Issue 2

American Journal of Ethnomedicine

ISSN 2348-9502

Natural Products Congress & World Pharma Congress 2017

October 16-18, 2017

3

rd

World Congress on

NATURAL PRODUCTS CHEMISTRY AND RESEARCH

&

12

th

WORLD PHARMA CONGRESS

October 16-18, 2017 Budapest, Hungary

A new 1,3-dihydroxy-2-methyl-11H-benzofuro[2,3-b]chromen-11-one isolated from

Abronia nana

,

inhibits High mobility group box-1 (HMGB1)-induced septic responses

Kyung-Sik Song, Eun-Ju Yang, Doohyun Lee, Wonhwa Lee, Jong-Sup Bae and Taeho Lee

Seoul National University, Republic of Korea

D

espite intensive investigation of molecular mechanisms underlying the pathogenesis of sepsis, many aspects of sepsis

remain unresolved, which hamper the development of appropriate therapeutics.

Abronia nana

is an ornamental plant

belonging to Nyctaginaceae, its pharmacological potential, especially against septic responses, has not been established

well. In the present study, we isolated a rarely new compound 1,3-dihydroxy-2-methyl-11H-benzofuro[2,3-b]chromen-11-

one (LDH1609) from

Abronia nana

. LDH1609 was investigated for its potential activities against HMGB1-mediated septic

responses. The data showed that LDH1609 effectively inhibited the Lipopolysaccharide (LPS)-induced release of High Mobility

Group Box-1 (HMGB1). The HMGB1-mediated septic responses were also significantly suppressed by LDH1609, including

hyperpermeability, leukocyte adhesion and migration, and cell adhesion molecule expression. In addition, LDH1609 inhibited

the HMGB1-mediated production of Tumor Necrosis Factor-α (TNF-α) and Interleukin (IL)-6, the activation of nuclear

factor-κB (NF-κB), and Extracellular Signal-Regulated Kinase (ERK) 1 and ERK2. These results demonstrate that LDH1609

might be applied to develop the potential therapeutic agents for various severe vascular inflammatory diseases through the

inhibition of the HMGB1 signaling pathway.

Biography

Kyung-Sik Song is a professor at Seoul National University, Republic of Korea. He has his expertise in Medicinal Chemistry. He has published more than 50 papers

in peer reviewed international journals.

kssong@knu.ac.kr

Kyung-Sik Song et al., American Journal of Ethnomedicine, 4:2

DOI: 10.21767/2348-9502-C1-003